Natural Killer‐Cell Cytotoxicity in HIV‐Positive and HIV‐Negative Patients with and Without Severe Course of Hepatitis B Virus Infection

Giulia Morsica(Vita-Salute San Raffaele University), Claudio Fortis(San Raffaele University of Rome), Carlo Paties(Vita-Salute San Raffaele University), Mauro Malnati(Vita-Salute San Raffaele University), Sabrina Bagaglio(Vita-Salute San Raffaele University), Silvana Tasca, Adriano Lazzarin(Vita-Salute San Raffaele University), M Marinelli(Policlinico Umberto I), Priscilla Biswas(Mario Negri Institute for Pharmacological Research)
Scandinavian Journal of Immunology
September 1, 2005
10.1111/j.1365-3083.2005.01659.x
Cited by 6

Related Papers

Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
|Nature Medicine|1997|635
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
|The Lancet|2009|620
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains
|Immunity|1995|574
CD46 Is a Cellular Receptor for Human Herpesvirus 6
|Cell|1999|525